Search results for "Neurologic"

showing 10 items of 473 documents

A case of atypical sporadic hemiplegic migraine associated with PFO and hypoplasia of vertebro-basilar system.

2009

We describe the case of a patient with atypical hemiplegic migraine and associated basilar symptoms, where a large patent foramen ovale (PFO) and hypoplasia of basilar artery were found. The longer period of 4-year remission of the headache attacks was coincident with the percutaneous PFO closure. When 5 years after, hemiplegic migraine attacks relapsed, with more relevant basilar symptoms, a mild re-opening of PFO was found. The atypical presentation of attacks with basilar symptoms and prolonged hemiplegia does not strictly fit the diagnostic criteria of ICHD-II.

AdultMalemedicine.medical_specialtyAuraMigraine with AuraClinical NeurologyForamen Ovale PatentHemiplegiaCase ReportNeurological disorderHemiplegic migraineRecurrencePFOmedicine.arteryBasilar arteryVertebrobasilar InsufficiencyMedicineHumansCardiac Surgical ProceduresBasilar type migrainebusiness.industryBasilar-Type MigraineAnticoagulantsBrainGeneral Medicinemedicine.diseaseMagnetic Resonance ImagingHypoplasiaMigraine with auraSurgeryAnesthesiology and Pain MedicineTreatment OutcomeVertebro-basilar system hypoplasiaMigraineBasilar ArteryPatent foramen ovalecardiovascular systemNeurology (clinical)sense organsmedicine.symptombusinessTomography X-Ray ComputedMagnetic Resonance AngiographyThe journal of headache and pain
researchProduct

Five years experience on 3,4-diaminopyridine phosphate in Lambert-Eaton syndrome: Case reports

2017

Abstract Rationale: To report our experience on 7 patients (4 males and 3 females), affected by nonparaneoplastic Lambert–Eaton myasthenic syndrome, treated with 3,4-diaminopyridine phosphate (3,4-DAPP) either alone or in combination with other immunosuppressants or steroids. Patient concerns: Patients have been evaluated at specific timepoints (ie, baseline and last 5 year follow-up), with neurological examination, autoantibodies against presynaptic voltage-gated Cav2.1 (P/Q type) calcium ion channel (VGCC) dosage, neurophysiological evaluation focusing on the increased amplitude of the compound muscle action potential (cMAP) after maximum voluntary effort, quantitative myasthenia gravis (…

AdultMalemedicine.medical_specialtyAzathioprineNeurological examination030204 cardiovascular system & hematologySeverity of Illness Index5300nonparaneoplastic-Lambert–Eaton myasthenic syndrome03 medical and health sciences0302 clinical medicinePrednisoneInternal medicineSeverity of illnessActivities of Daily LivingAzathioprinemedicineHumansMuscle StrengthClinical Case Report4-AminopyridineAdverse effect34-diaminopyridine phosphate; nonparaneoplastic-Lambert-Eaton myasthenic syndrome; 4-Aminopyridine; Activities of Daily Living; Adult; Azathioprine; Drug Therapy Combination; Female; Humans; Immunosuppressive Agents; Lambert-Eaton Myasthenic Syndrome; Male; Middle Aged; Muscle Strength; Prednisone; Severity of Illness Index; Treatment Outcome; Medicine (all)medicine.diagnostic_testbusiness.industry34-diaminopyridine phosphateGeneral MedicineMiddle Agedmedicine.diseaseMyasthenia gravisLambert-Eaton Myasthenic SyndromeTreatment OutcomeConcomitantPrednisoneDrug Therapy CombinationFemaleAmifampridinebusinessLambert-Eaton myasthenic syndrome030217 neurology & neurosurgeryImmunosuppressive Agentsmedicine.drugResearch Article
researchProduct

[123I]IBZM SPECT in patients treated with typical and atypical neuroleptics: relationship to drug plasma levels and extrapyramidal side effects

1997

[123I]Iodobenzamide (IBZM) is an iodine-labeled dopamine receptor ligand and can be used to visualize brain D2 receptors in humans with single photon emission computerized tomography (SPECT). The ratio of striatal IBZM uptake to uptake in frontal cortex (ST/FC ratio) represents a semiquantitative measure of D2 receptor binding in the striatum. Our study sample included six patients treated with haloperidol (3.0-8.0 mg/day orally; one patient with an average of 0.9 mg/day intramuscularly), five patients with benperidol (9.0-15.0 mg/day orally) and nine patients treated with clozapine (200.0-600.0 mg/day orally). Typical neuroleptics (TNs) and atypical neuroleptics (ANs) were significantly di…

AdultMalemedicine.medical_specialtyBipolar DisorderPyrrolidinesNeuroscience (miscellaneous)Benperidolchemistry.chemical_compoundIodobenzamideBasal Ganglia DiseasesDopamineInternal medicineDopamine receptor D2medicineHaloperidolHumansRadiology Nuclear Medicine and imagingChlorpromazineClozapineClozapineAgedNeurologic ExaminationPsychiatric Status Rating ScalesTomography Emission-Computed Single-PhotonDepressive Disorder MajorSchizophrenia ParanoidDose-Response Relationship DrugReceptors Dopamine D2business.industryBenperidolBrainMiddle AgedCorpus StriatumFrontal LobePsychiatry and Mental healthEndocrinologychemistryDopamine receptorBenzamidesDopamine AntagonistsHaloperidolFemalebusinessAntipsychotic Agentsmedicine.drugPsychiatry Research: Neuroimaging
researchProduct

Increased gait variability during robot-assisted walking is accompanied by increased sensorimotor brain activity in healthy people

2019

Abstract Background Gait disorders are major symptoms of neurological diseases affecting the quality of life. Interventions that restore walking and allow patients to maintain safe and independent mobility are essential. Robot-assisted gait training (RAGT) proved to be a promising treatment for restoring and improving the ability to walk. Due to heterogenuous study designs and fragmentary knowlegde about the neural correlates associated with RAGT and the relation to motor recovery, guidelines for an individually optimized therapy can hardly be derived. To optimize robotic rehabilitation, it is crucial to understand how robotic assistance affect locomotor control and its underlying brain act…

AdultMalemedicine.medical_specialtyBrain activity and meditationHealth InformaticsSensory systemNeuroimagingfNIRSWalking050105 experimental psychologylcsh:RC321-571Premotor cortex03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationGait trainingmedicineHumans0501 psychology and cognitive sciencesTreadmilllcsh:Neurosciences. Biological psychiatry. NeuropsychiatryRAGTGaitGait Disorders NeurologicBrain MappingSupplementary motor areabusiness.industryRobotic rehabilitationResearch05 social sciencesRehabilitationGait variabilityBrainRoboticsSelf-Help DevicesGaitExercise Therapymedicine.anatomical_structureGRFNeurorehabilitationFunctional near-infrared spectroscopyFemalebusinessBrain activityhuman activities030217 neurology & neurosurgeryFunctional near-infrared spectroscopyJournal of NeuroEngineering and Rehabilitation
researchProduct

Breathing 100% oxygen during water immersion improves postimmersion cardiovascular responses to orthostatic stress

2016

Abstract Physiological compensation to postural stress is weakened after long‐duration water immersion (WI), thus predisposing individuals to orthostatic intolerance. This study was conducted to compare hemodynamic responses to postural stress following exposure to WI alone (Air WI), hyperbaric oxygen alone in a hyperbaric chamber (O 2 HC), and WI combined with hyperbaric oxygen (O 2 WI), all at a depth of 1.35 ATA, and to determine whether hyperbaric oxygen is protective of orthostatic tolerance. Thirty‐two healthy men underwent up to 15 min of 70° head‐up tilt (HUT) testing before and after a single 6‐h resting exposure to Air WI ( N  = 10), O 2 HC ( N  = 12), or O 2 WI ( N  = 10). Heart …

AdultMalemedicine.medical_specialtyCardiac outputPhysiologyDivingOrthostatic intoleranceHemodynamicsBlood PressureNeurological Conditions Disorders and Treatments03 medical and health sciencesOrthostatic vital signs0302 clinical medicinePhysiology (medical)Internal medicineHeart rateImmersionMedicineAutonomic nervous systemblood flowHumansOriginal ResearchPresyncopeRespiratory Conditions Disorder and DiseasesHyperbaric Oxygenationbusiness.industryRespirationheart rate variabilityHeartStroke Volume030229 sport sciencesmedicine.diseaseSurgeryOxygenmedicine.anatomical_structureBlood pressureAutonomic nervous system; Blood flow; Blood pressure; Heart rate variability; Hyperoxia; Orthostatic tolerance; Water immersion; Adult; Diving; Humans; Hyperbaric Oxygenation; Immersion; Male; Orthostatic Intolerance; Oxygen; Vascular Resistance; Blood Pressure; Respiration; Stroke Volume; Physiology; Physiology (medical)Settore ING-INF/06 - Bioingegneria Elettronica E InformaticaVascular resistanceCardiologyOrthostatic Intolerancehyperoxiawater immersionorthostatic toleranceVascular Resistancebusiness030217 neurology & neurosurgeryHumanPhysiological Reports
researchProduct

A multidisciplinary approach to assess recovery of consciousness in a patient with moyamoya disease

2019

Abstract Introduction Moyamoya disease (MMD) meaning “hazy puff of smoke” in Japanese is a rare chronic cerebrovascular syndrome characterized by progressive stenosis and occlusion of the internal carotid arteries (ICAs) anterior cerebral arteries (ACAs), and middle cerebral arteries (MCAs). Methods Our moyamoya patient with severely impaired cognitive and motor functions underwent a specific motor and neuropsychological rehabilitative treatments to assess the recovery of consciousness. Results Results obtained showed an improvement of clinical and neuropsychological examination. These findings highlighted the importance of an intensive rehabilitation techniques used in the care of disorder…

AdultMalemedicine.medical_specialtyConsciousnessmedicine.medical_treatmentCerebral arteriesNeuropsychological Tests050105 experimental psychologyrehabilitation03 medical and health sciencesBehavioral Neuroscience0302 clinical medicinePhysical medicine and rehabilitationOcclusionmedicineHumans0501 psychology and cognitive sciencesCarotid StenosisCognitive DysfunctionMoyamoya diseasedisorders of consciousnessneuropsychological evaluationPersistent vegetative stateOriginal ResearchRehabilitationbusiness.industry05 social sciencesNeuropsychologyNeurological RehabilitationCognitionRecovery of Functionmedicine.diseaseStenosisTreatment OutcomeItalyMotor SkillsCerebral Arterial DiseasesMoyamoya Diseasebusiness030217 neurology & neurosurgeryBrain and Behavior
researchProduct

Reliability of the Dynamic Gait Index (Finnish version) in individuals with neurological disorders

2012

To produce a Finnish version of the Dynamic Gait Index (DGI) and establish its reliability in people with neurological disorders affecting balance.A consecutive sample of 33 participants in inter-rater and 30 participants in intra-rater sample were tested. The DGI was administered in two testing sessions 1-2 h apart. Reliability was assessed with the intra-class correlation coefficient (ICC), Bland-Altman 95% limits of agreement, coefficient of reproducibility (CR), and standard error of the mean (SEM).The instructions from the original DGI were preserved during the translation process with no need for cultural adaptations. The relative reliability of the total scores proved to be high in i…

AdultMalemedicine.medical_specialtyCorrelation coefficientStatistics NonparametricCONSECUTIVE SAMPLEDisability EvaluationPhysical medicine and rehabilitationmedicineHumansPostural BalanceFinlandGait Disorders NeurologicReliability (statistics)AgedBalance (ability)Aged 80 and overObserver VariationReproducibilityDynamic gait indexRehabilitationReproducibility of Resultsta3141Middle AgedGaitStandard errorPhysical therapyFemalePsychologyDisability and Rehabilitation
researchProduct

Outcome after palliative posterior surgery for metastatic disease of the spine - evaluation of 106 consecutive patients after decompression and stabi…

1999

From 1987 to 1996, 106 consecutive patients with metastatic disease of the spine who underwent palliative decompression from a dorsal approach and subsequent stabilisation with Cotrel-Dubousset instrumentation (CDI) were followed prospectively, and independent of the surgeons. Parameters evaluated were neurological function, perioperative complications, survival and rehabilitation. Following the Frankel system for the assessment of neurological disorder, 33 patients had a major deficit (grade A, B or C), 23 a minor deficit (grade D) and 50 no deficit. If there was no neurological dysfunction, the only patients who underwent operation were those graded as class IV according to Harrington. Ou…

AdultMalemedicine.medical_specialtyDecompressionmedicine.medical_treatmentNeurological disorderBone graftingCotrel–Dubousset instrumentationHumansMedicineOrthopedics and Sports MedicineRachisAgedParesisAged 80 and overSpinal Neoplasmsbusiness.industryPalliative CareGeneral MedicinePerioperativeMiddle AgedDecompression Surgicalmedicine.diseaseMagnetic Resonance ImagingSurgeryTreatment OutcomeOrthopedic surgeryFemaleSurgerymedicine.symptombusinessArchives of Orthopaedic and Trauma Surgery
researchProduct

Sensory phenotype and risk factors for painful diabetic neuropathy: a cross-sectional observational study.

2017

Different sensory profiles in diabetic distal symmetrical sensory-motor polyneuropathy (DSPN) may be associated with pain and the responsiveness to analgesia. We aimed to characterize sensory phenotypes of patients with painful and painless diabetic neuropathy and to assess demographic, clinical, metabolic, and electrophysiological parameters related to the presence of neuropathic pain in a large cohort of well-defined DSPN subjects. This observational cross-sectional multi-center cohort study (performed as part of the ncRNAPain EU consortium) of 232 subjects with nonpainful (n = 74) and painful (n = 158) DSPN associated with diabetes mellitus of type 1 and 2 (median age 63 years, range 21-…

AdultMalemedicine.medical_specialtyDiabetic neuropathyAnalgesic030209 endocrinology & metabolismNeurological examinationCohort Studies03 medical and health sciencesPolyneuropathiesYoung Adult0302 clinical medicineDiabetic NeuropathiesRisk FactorsInternal medicineDiabetes mellitusmedicineHumansAgedAged 80 and overNeurologic Examinationmedicine.diagnostic_testbusiness.industryMiddle Agedmedicine.diseaseAnesthesiology and Pain MedicineCross-Sectional StudiesPhenotypeNeurologyNeuropathic painPhysical therapyNeuralgiaPain catastrophizingFemaleNeurology (clinical)businessPolyneuropathy030217 neurology & neurosurgeryCohort studyPain
researchProduct

Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia.

2005

Amisulpride is a clinically effective antipsychotic drug in a broad dose range with low propensity for extrapyramidal symptoms (EPS). Daily doses and plasma levels of amisulpride were analyzed within a large-scale therapeutic drug monitoring (TDM) survey to find plasma level ranges for optimized treatment under naturalistic conditions. Data of 378 schizophrenic patients treated with amisulpride (100-1550 mg) were included (40% female). Amisulpride plasma levels were analyzed at steady state; assessment comprised improvement (CGI-I) and side-effects, particularly EPS. For detection of cut-off values regarding non-response or EPS, receiver operating characteristics (ROC) curves were applied a…

AdultMalemedicine.medical_specialtyDyskinesia Drug-InducedAdolescentmedicine.drug_classStatistics as TopicAtypical antipsychoticPharmacologyGastroenterologyExtrapyramidal symptomsInternal medicineGermanymedicineHumansAmisulprideBiological PsychiatryAgedRetrospective StudiesAged 80 and overNeurologic ExaminationPsychiatric Status Rating ScalesReceiver operating characteristicmedicine.diagnostic_testDose-Response Relationship Drugbusiness.industryDopamine antagonistMiddle Agedmedicine.diseasePsychiatry and Mental healthDose–response relationshipROC CurveSchizophreniaTherapeutic drug monitoringSchizophreniaFemalemedicine.symptomAmisulprideDrug MonitoringSulpiridebusinessmedicine.drugAntipsychotic AgentsJournal of psychiatric research
researchProduct